Anrikefon vs Nalfurafine for Sleep Quality in Hemodialysis Patients With CKD-aP | MicrobiomeTrials← Back to trialsNCT07380113
Anrikefon vs Nalfurafine for Sleep Quality in Hemodialysis Patients With CKD-aP
RecruitingPHASE4INTERVENTIONAL
Trial Details
Start: 2026-07-01Est. Completion: 2027-12-31
Enrollment target: 50 participants Other microbiome trials you might be interested in
Video-assisted Thoracoscopic Surgery (VATS)Wedge ResectionSegmentectomyLobectomy of the LungsIncisional InfiltrationTriamcinolone
Video-assisted thoracoscopic surgery (VATS) is less invasive compared to traditional thoracotomy, but it is still report…
Beijing, ChinaEst. completion May 31, 2027
Chronic Kidney Disease-Associated Pruritus in Hemodialysis
This is a randomized, open-label, multi-center clinical study aimed at evaluating the efficacy and safety of 12 weeks of…
Beijing, China
Est. completion Dec 31, 2028